Delcath Systems price to free cash flow DCTH
Market value divided by free cash flow over the last twelve months, since 2025.
- Today, Oct 23, 2026
- 28.6×
- Peer median
- 16.7×
Delcath Systems' price to free cash flow is 28.6× as of Oct 23, 2026.
The median for 10 medical instruments and supplies stocks of a similar size is 16.7×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 28.6× | 14.7× | 34.0× |
| 2025 | 30.2× | 25.3× | 108× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Delcath Systems' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| DCTHDelcath Systems | 28.6× |
| TCMDTactile Systems Technology | 20.0× |
| MDXGMimedx | n/m |
| EMBCEmbecta | 2.3× |
| MOVMovado | 9.8× |
| INFUInfuSystem | 12.1× |
| UTMDUtah Medical Products | 20.6× |
| IRMDIradimed | 43.7× |
| STAAStaar Surgical | n/m |
| PDEXPro DEX | 29.5× |
| BVSBioventus | 13.3× |
| Peer median | 16.7× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Delcath Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.